What did the CES 2026 pilot study show?

The 2026 CES pilot is small-scale exploratory research conducted with KBSI and Gachon University College of Medicine over 6 weeks. Observed volumetric changes included +1.835% hippocampal and +1.798% cerebellar regions. These results are promising but preliminary and have not been peer-reviewed. Systematic MRI + AI studies are currently in progress, and a confirmatory RCT is planned for 2027.

When will Neurélux be available for purchase?

Neurélux is currently in pre-launch phase. Pricing and availability have not yet been announced. Please submit an inquiry to receive product launch alerts, or for clinical collaboration and distribution partnership inquiries.

Neurélux — Brain Wellness Device by Korea Lighting Inc.

Q: What makes Neurélux different from other tPBM devices?

Three key differentiators: ① 810nm + 1064nm Dual Wavelength — rarely used in combination in home devices. ② HS FRAME™ Patented Thermal Management — 1.75 K/W thermal resistance (37× lower than conventional 65 K/W) ensures wavelength stability and consistent output. ③ Fanless Silent Operation — natural convection heat dissipation. Zero noise, zero vibration.

Q: Is Neurélux an approved medical device?

Neurélux is currently positioned as a brain wellness device, not an approved medical device. A clinical roadmap is underway with confirmatory RCT trials planned for 2027 to support future regulatory approval. All current research data is exploratory and does not constitute medical claims.

Mechanism

How Transcranial PBM Works

Four steps from photon to brain wellness

🔬

Photon Delivery

810nm & 1064nm near-infrared light penetrates the skull and reaches brain tissue through non-invasive transcranial delivery.

Skull Penetration

⚡

Cellular Absorption

Cytochrome c oxidase (CCO) in neuronal mitochondria absorbs the near-infrared photons, initiating a photochemical cascade.

CCO Activation

🔋

ATP Synthesis

Mitochondrial energy production (ATP synthesis) is supported, potentially enhancing cellular metabolism and neural function.

Mitochondrial Energy

🧠

Brain Wellness

Ongoing research explores cognitive conditioning, neural connectivity, and long-term brain wellness outcomes.

Wellness Outcomes

Dual Wavelength

810nm + 1064nm

A wavelength combination not widely adopted in other home tPBM devices

810nm

Primary Cortical Targeting

Key absorption band for cytochrome c oxidase (CCO). Well-established in transcranial PBM research for cortical stimulation and neural activation.

Primary CCO absorption window
Cortical layer penetration
Extensively studied in tPBM research

1064nm

Deep Penetration Potential

Exploratory research ongoing. 1064nm demonstrates deeper tissue penetration potential, targeting structures beyond the cortical surface.

Deeper penetration depth potential
Complementary to 810nm
Rarely adopted in home devices

1064nm research is exploratory. Final clinical efficacy is subject to further peer-reviewed studies.

Proprietary Technology · 16 Years R&D

HS FRAME™ All-in-One Optical Semiconductor

The core platform innovation that makes stable, medical-grade high-power tPBM possible

1.75 K/W

Thermal Resistance

37×

Lower vs. Conventional

10×

Faster Heat Dissipation

30%

Junction Temp Reduction

2×

Longer Lifespan

Conventional LED Structure

8-Step Complex Thermal Transfer Path

LED Chip (Heat Source) 🔴

Solder

PCB Substrate

Thermal Paste (TIM)

Aluminum Heat Sink

Thermal Bottleneck

High heat load

Delayed dissipation

65 K/W

High Thermal Resistance

Droop — output degradation from heat buildup
Wavelength shift — efficacy loss under thermal load
Bulky heatsink — added weight and complex structure

Conventional LED chip thermal path visualization

Conventional LED module — complex multi-layer stack

10× thermal performance improvement

HS FRAME™

Direct Thermal Path — All-in-One Structure

Chip + Circuit + Heat Sink — unified in one structure

LED Chip

Direct bonding — no intermediate layers

HS FRAME™ Integrated Optical Semiconductor Module

Smooth Thermal Flow

Heat dissipated across full surface area

1.75 K/W

Dramatically Lower Thermal Resistance

Fanless (Silent)

Stable Wavelength

Lightweight Design

2× Longer Lifespan

HS FRAME All-in-One integrated LED module

HS FRAME™ module — chip · circuit · heat sink unified

🏆

7-Country Patent Portfolio Registered across KR · US · EU · JP · CN · and more

🔬

16 Years of Dedicated R&D 110B KRW cumulative R&D investment since 2010

🎖️

Innovation Product Designation Korea Public Procurement Service certified

* Based on internal testing vs. conventional 65 K/W design. Junction temperature reduction and lifespan data derived from thermal simulation and internal lab testing. No Wavelength Droop confirmed under continuous operation.

Product Lineup

Neurélux Lineup

Two configurations for every brain wellness need

Series 01

Neurélux Desk

Focus Care · Prevention

A precision photobiomodulation desk device designed for daily brain wellness sessions. Compact form factor, silent operation — fits seamlessly into any home or office setup.

Wavelength 810nm + 1064nm
Contact Non-contact
Noise Fanless · Silent
Use Home / Office
Optical System 18W Power

Brain Coverage 55%

Frontal / Temporal Region

Inquire

FLAGSHIP

Series 02

Neurélux Stand Pro

Whole-Brain Care · Premium

The flagship full-transcranial tPBM device. Engineered for comprehensive brain wellness — from prefrontal cortex to deep cerebellar structures. Adjustable arm for precise positioning.

Wavelength 810nm + 1064nm
Contact Non-contact
Noise Fanless · Silent
Use Home / Office
Optical System 45W High-Power
Coverage Full Transcranial

Brain Coverage 95%

Full Transcranial — Frontal · Temporal · Parietal · Occipital

Inquire

* Pricing and availability to be announced. Specifications subject to change prior to commercial launch.

Research Roadmap

Research Progress

From exploratory pilot to confirmatory clinical evidence

✅

Completed 2026.03

KBSI & Gachon Univ. Exploratory Pilot

6-week exploratory pilot study collaboratively measured with the Korea Basic Science Institute and Gachon University College of Medicine. Observed volumetric changes in hippocampal and cerebellar regions.

fMRI 6-Week Pilot Study CES 2026

🔬

In Progress 2026

MRI · AI-Based Systematic Study

Collaboration with M-Tech Lab. MRI + AI-based brain analysis methodology. SCI(E) journal paper in preparation for peer-reviewed publication.

MRI + AI M-Tech Lab SCI(E) Paper

📋

Planned 2027

Confirmatory RCT Clinical Trial

Full-scale randomized controlled trial (RCT) planned for 2027. Target: regulatory approval pathway and peer-reviewed clinical evidence.

RCT Clinical Trial Regulatory Pathway

FAQ

Frequently Asked Questions

Key questions about Neurélux answered

How does Neurélux work?

Near-infrared light at 810nm and 1064nm penetrates the skull and is absorbed by cytochrome c oxidase (CCO) in neuronal mitochondria. This photochemical reaction may support mitochondrial ATP synthesis and cellular energy metabolism. Neurélux is a non-contact, home-use brain wellness device — not a medical treatment.

Is it a medical device?

Neurélux is currently positioned as a home medical platform undergoing rigorous clinical validation, rather than a simple wellness device. A clinical roadmap is underway with confirmatory RCT trials planned for 2027 to support future regulatory approval. All current research data is exploratory and does not constitute medical claims.

What makes it different from other home tPBM devices?

Three key differentiators set Neurélux apart:

① 810nm + 1064nm Dual Wavelength — rarely used in combination in home devices. Most home tPBM devices use only a single wavelength.

② HS FRAME™ Patented Thermal Management — 1.75 K/W thermal resistance (37× lower than conventional 65 K/W) ensures wavelength stability and consistent output throughout each session.

③ Fanless Silent Operation — natural convection heat dissipation. Zero noise, zero vibration.

Is the fMRI pilot data reliable?

The 2026 The exploratory pilot study, collaboratively measured with the Korea Basic Science Institute (KBSI) and Gachon University College of Medicine, is small-scale research and has not been peer-reviewed. The observed volumetric changes (+1.835% hippocampal, +1.798% cerebellar) are promising but preliminary. Systematic studies using MRI + AI analysis are currently in progress with M-Tech Lab, and a confirmatory RCT is planned for 2027. Final efficacy confirmation awaits further peer-reviewed clinical research.

When will Neurélux be available?

Neurélux is currently in pre-launch phase. Pricing and availability have not yet been announced. Please submit an inquiry below to receive product launch alerts, or for clinical collaboration and distribution partnership inquiries.

Exploratory Pilot fMRI Data — 6 Weeks